Komori
Techno Medica (6678) · PolicyAdvanced

Enhancing Management Transparency and Efficiency and Establishing a Body for Prompt Decision-Making

First written in FY2017-Q2. 4 of 8 entries say "Restated". Latest entry: FY2026.

8entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q2 – FY2022AdvancedFY2024 – FY20262016: 12017: 020172018: 120182019: 120192020: 020202021: 120212022: 120222023: 020232024: 120242025: 120252026: 12026
Same theme, other companies
Corporate Governance Focused on Efficiency, Legal Compliance, and TransparencyA theme 460 companies write about · 2 as a headwind · 460 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 463 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「During the fiscal year, the company held 15 meetings of the Board of Directors. The attendance record of each director is as follows.」

    The company disclosed that the Board of Directors met 15 times and showed the status of its deliberations on progress management for the medium-term management plan and budget, management conscious of the cost of capital and share price, human capital, compliance, risk management and sustainability.
  2. FY2025AdvancedAnnual report

    「During the fiscal year, the company held 13 meetings of the Board of Directors. The Board considered a wide range of topics, including progress management for the “2030 Long-Term Vision” and the “Medium-Term Management Plan,” initiatives aimed at achieving management that is conscious of the cost of capital and share price, efforts related to human capital management, and initiatives related to compliance, risk management and sustainability.」

    The company disclosed 13 Board of Directors meetings during the year and deliberations on progress management for the medium-term plan, management conscious of the cost of capital and share price, human capital and sustainability.
  3. FY2024AdvancedAnnual report

    「During the fiscal year, the company held 14 meetings of the Board of Directors. The Board considered a wide range of topics, including the formulation and progress management of the “2030 Long-Term Vision” and the “Medium-Term Management Plan,” as well as key themes for the company, including capital policy, enhancement of human capital, the SDGs and ESG, together with initiatives related to compliance, risk management and sustainability.」

    The company disclosed that it held 14 Board of Directors meetings during the year and considered the formulation and progress management of its long-term vision and medium-term management plan, as well as capital policy, human capital, ESG, compliance and risk management.
  4. FY2022RestatedAnnual report

    「We regard improving management transparency and efficiency, making effective use of management resources, and establishing a decision-making body capable of responding swiftly to changes in the business environment as the foundation of corporate governance.」

    The company has reaffirmed a governance policy that emphasizes management transparency and efficiency, effective use of management resources, and swift decision-making.
  5. FY2021RestatedAnnual report

    「We regard improving management transparency and efficiency, making effective use of management resources, and establishing a decision-making body capable of responding swiftly to changes in the business environment as the foundation of corporate governance.」

    The company has reaffirmed a governance policy that emphasizes management transparency and efficiency, effective use of management resources, and swift decision-making.
  6. FY2019RestatedAnnual report

    「We regard improving management transparency and efficiency, making effective use of management resources, and establishing a decision-making body capable of responding swiftly to changes in the business environment as the foundation of corporate governance.」

    The company has reaffirmed a governance policy that emphasizes management transparency and efficiency, effective use of management resources, and swift decision-making.
  7. FY2018RestatedAnnual report

    「In accordance with our audit policies and other guidelines, we audit the overall execution of the directors’ duties in order to continue maintaining a stable and streamlined earnings base, management transparency and efficiency, and established corporate ethics.」

    The company continues to pursue a governance policy that prioritizes a stable earnings base, management transparency and efficiency, and established corporate ethics.
  8. FY2017-Q2First statedAnnual report

    「We formulate management policies aimed at maximizing corporate value while working to improve management transparency and efficiency, invest management resources effectively, and establish a decision-making body capable of responding swiftly to changes in the business environment.」

    The management policy emphasizes transparency and efficiency, effective investment of management resources, and the establishment of a decision-making body capable of responding to changes in the business environment.
Moved together

"Disposal of Treasury Shares as Restricted Stock Compensation" moved the same way as this thread, in the same document, in 3 of its 8 moves.

333322★123456
  1. ★This thread
  2. 1Disposal of Treasury Shares as Restricted Stock Compensation3×
  3. 2Expansion of Recurring Sales through Related Consumables and Maintenance Services3×
  4. 3Initiatives for Value-Added Products Focused on Medical Safety and Quality of Life3×
  5. 4Addressing Social Issues through SDGs and ESG under the 2030 Long-Term Vision3×
  6. 5Expanding Market Share of Blood Collection Tube Preparation Equipment2×
  7. 6Reduced dependence on blood collection tube preparation equipment through the expansion of specimen testing equipment2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Techno Medica yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enhancing Management Transparency and Efficiency and Establishing a Body for Prompt Decision-Making | Techno Medica Co.,Ltd. (6678) | Komori